CG Oncology, Inc. (CGON)

NASDAQ: CGON · Real-Time Price · USD

74.86

-1.00 (-1.32%)

Sep 2, 2026, 10:59 AM EDT - Market open

CG Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.64	32.49	257.07	8.27	88.14	53.61
Short-Term Investments	1,009	709.67	484.93	179.41	55.34	-
Cash & Short-Term Investments	1,028	742.16	742	187.67	143.48	53.61
Cash Growth	55.55%	0.02%	295.37%	30.80%	167.65%	-
Accounts Receivable	0.42	0.69	-	-	-	-
Other Receivables	-	-	-	0.09	0.3	0
Receivables	0.42	0.69	-	0.09	0.3	0
Inventory	1	1.57	-	-	-	-
Prepaid Expenses	19.95	15.07	12.21	6.36	3.42	4.8
Total Current Assets	1,050	759.48	754.21	194.12	147.21	58.41
Property, Plant & Equipment	20.44	19.57	0.49	0.49	0.51	0.2
Goodwill	10.3	10.3	-	-	-	-
Other Intangible Assets	0.55	0.58	-	-	-	-
Long-Term Deferred Charges	-	-	-	4.67	-	-
Other Long-Term Assets	4.73	1.68	0.09	0.02	0.03	0.09
Total Assets	1,086	791.59	754.8	199.3	147.75	58.69

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	12.73	5.71	6.52	3.24	0.99	1
Accrued Expenses	31.85	23.12	14.23	9.68	5.12	1.89
Current Portion of Long-Term Debt	-	-	-	-	8.97	2.94
Current Portion of Leases	0.99	0.92	0.19	0.22	0.19	0.07
Current Unearned Revenue	0.23	0.29	-	-	-	-
Other Current Liabilities	1.45	0.8	0.44	1.12	0.17	0.07
Total Current Liabilities	47.24	30.84	21.37	14.25	15.43	5.98
Long-Term Debt	3	3	-	-	6.53	12.06
Long-Term Leases	4.83	3.11	0.05	0.24	0.26	0.05
Long-Term Deferred Tax Liabilities	0.31	0.31	-	-	-	-
Other Long-Term Liabilities	1.16	1.74	-	0.01	0.35	0.35
Total Liabilities	56.54	38.99	21.42	14.51	22.57	18.44

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	-	-	0
Additional Paid-In Capital	1,547	1,132	951.35	6.84	3.64	3.27
Retained Earnings	-518.23	-378.98	-217.98	-129.94	-81.34	-45.89
Total Common Equity	1,029	752.6	733.38	-123.1	-77.69	-42.62
Shareholders' Equity	1,029	752.6	733.38	184.79	125.18	40.25
Total Liabilities & Equity	1,086	791.59	754.8	199.3	147.75	58.69

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	8.82	7.02	0.24	0.46	15.94	15.13
Net Cash (Debt)	1,019	735.13	741.76	187.21	127.54	38.48
Net Cash Growth	54.45%	-0.89%	296.21%	46.79%	231.45%	-
Net Cash Per Share	12.37	9.51	11.87	43.23	34.09	10.54
Filing Date Shares Outstanding	88.64	84.44	76.22	66.64	3.84	3.65
Total Common Shares Outstanding	88.31	80.69	76.15	5.22	3.84	3.65
Working Capital	1,002	728.64	732.84	179.87	131.78	52.43
Book Value Per Share	11.65	9.33	9.63	-23.57	-20.22	-11.67
Tangible Book Value	1,018	741.73	733.38	-123.1	-77.69	-42.62
Tangible Book Value Per Share	11.53	9.19	9.63	-23.57	-20.22	-11.67
Machinery	7.06	6.57	0.36	-	-	-
Leasehold Improvements	10.71	10.5	-	-	-	-

SEC Filings: 10-K · 10-Q